Health - Google News: Actelion surges as positive PhIII macitentan data reignites buyout buzz - FierceBiotech

Health - Google News Google News

Actelion surges as positive PhIII macitentan data reignites buyout buzz - FierceBiotech Apr 30th 2012, 12:26 Bloomberg Actelion surges as positive PhIII macitentan data reignites buyout buzz FierceBiotech Actelion cleared a crucial hurdle today, reporting that its late-stage study of macitentan for pulmonary arterial hypertension beat the primary endpoint. The data clears a path to the regulatory agencies, signaling to investors that the Swiss company ... Actelion's macitentan meets goal in studyReuters Actelion Lung Drug Meets Main Goal in Pivotal StudyBusinessWeek Actelion breathes easy on "best case" new drug dataChicago Tribune Bloomberg -MarketWatch all 34 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: